Genentech’s TNKase gets new approval; Sanofi gives up rights to oncology candidate

Plus, news about Nuvation Bio, Leqembi, IN8bio and Syros:

Longtime clot-busting drug gets new approval: Roche and Genentech’s TNKase (tenecteplase) was

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

China’s NMPA approves Antengene’s XPOVIO for DLBCL treatment

One of the most prevalent subtypes of adult non-Hodgkin lymphoma is diffuse large B-cell lymphoma. Credit: Nemes Laszlo/ Shutterstock. China’s National Medical Products Administration (NMPA)

July 8, 2024

Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb 08.01.2024 / 07:30 CET/CEST The issuer is

January 9, 2024

Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s Special Access Program – Psychedelic Alpha

Veteran to receive APEX-90 macrodose psilocybin drug product in combination with assisted psychotherapy consistent with SUMMIT-90 clinical trial protocol. VANCOUVER, BC, Sept. 27, 2023 /CNW/

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.